Table 2. Description of CSF biomarker and CAMCOG in groups.
Tau [pg/ml] | P181-Tau [pg/ml] | Alb. ratio [csf/serum] | ||||
Median | min–max | Median | min–max | Median | min–max | |
Controls | 156 | <75 – 635 | 39 | 16 – 78 | 6.10 | 2.8 – 13.2 |
Group 1 | 148 | <75 – 1033 | 34 | 16 – 87 | 8.35 | 3.7 – 28.6 |
Group 2 | 390 | <75 – 2120 | 94 | 15 – 224 | 6.70 | 2.7 – 12.6 |
AD no CSVD | 610 | 195 – 2022 | 101 | 52 – 295 | 5.8 | 2.6 – 12.9 |